Platelet-activating factor inactivator (rPAF-AH) enhances liver's recovery after paracetamol intoxication

Digestive Diseases and Sciences

Volumn 52, Issue 10, 2007, Pages 2580-2590

  Grypioti, A D ^a,b,c,d   Kostopanagiotou, G ^a,b   Mykoniatis, M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c BioAnalytica   (Greece)

^d NONE   (Greece)

Author keywords

Injury; Liver; Paracetamol (acetaminophen); Platelet activating factor (PAF); Recombinant PAF acetylhydrolase; Regeneration

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROLASE; MALONALDEHYDE; PARACETAMOL; PHOSPHOLIPID DERIVATIVE; RECOMBINANT PLATELET ACTIVATING FACTOR ACETYLHYDROLASE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG INTOXICATION; ENZYME ACTIVITY; HISTOPATHOLOGY; LABORATORY TEST; LETHAL DOSE; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; COLORIMETRY; DISEASE MODELS, ANIMAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATITIS, TOXIC; HEPATOCYTES; INJECTIONS, INTRAPERITONEAL; LIVER; MALE; MALONDIALDEHYDE; MITOSIS; OXIDATIVE STRESS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; RECOVERY OF FUNCTION; THYMIDINE KINASE; TRANSAMINASES; ULTRACENTRIFUGATION;

EID: 34548492952     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9728-6     Document Type: Article

References (56)

1. Bessems JG, Vermeulen NP (2001) Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 31:55-138
2. Larsen FS, Kirkegaard P, Rasmussen A, Hansen BA (1995) The Danish liver transplantation program and patients with serious acetaminophen intoxication. Transplant Proc 27:3519-3520
3. Tsai CL, Chang WT, Weng TI, Fang CC, Chen WJ (2004) Acute acetaminophen intoxication in Taiwan: outcomes and risk factors. J Formos Med Assoc 103:830-835
4. Sciodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, Stribling R (1995) Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 5:29-34
5. Sidney D, Nelson MD (1990) Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 10:267-278
6. Dahlin DC, Miwa GT, Lu AY, Nelson SD (1984) N-Acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 81:1327-1331
7. Gujral JS, Bucci TJ, Farhood A, Jaeschke H (2001) Mechanism of cell death during hepatic ischemia-reperfusion in rats: Apoptosis or necrosis? Hepatology 33:397-405
8. Gujral JS, Knight TR, Farhood A, Bajt ML, Jaeschke H (2002) Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 67:322-328
9. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH (1988) Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 319:1557-1562
10. 2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 7:453-463
11. Liakos AA, Mykoniatis MG, Kokala ME, Papadimitriou DG, Liatsos GD (1999) Levels of hepatic stimulator substance in the liver regenerating process of partially hepatectomized rats pretreated with a single dose of carbon tetrachloride. Dig Dis Sci 44:1046-1053
12. Liatsos GD, Mykoniatis MG, Margeli A, Liakos AA, Theocharis SE (2003) Effect of acute ethanol exposure on hepatic stimulator substance (HSS) levels during liver regeneration: protective function of HSS. Dig Dis Sci 48:1929-1938
13. Margeli AP, Papadimitriou L, Ninos S, Manolis E, Mykoniatis MG, Theocharis SE (2003) Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy. Liver Int 23:171-178
14. Margeli AP, Manolis E, Skaltsas SN, Tsarpalis KS, Mykoniatis MG, Theocharis SE (2002) Hepatic Stimulator Substance in an animal model of fulminant hepatic failure and encephalopathy. Dig Dis Sci 47:2170-2178
15. Tzirogiannis KN, Liakos AA, Margeli AP, Theocharis SE, Mykoniatis MG (1998) The levels of hepatic stimulator substance (HSS) in liver regeneration after cadmium intoxication and partial hepatectomy. Arch Pharmacol 358:5412
16. Hanahan DJ (1986) Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem 55:483-509
17. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69:419-445
18. Montrucchio G, Alloatti G, Camussi G (2000) Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80:1669-1699
19. Karasawa K, Harada A, Satoh N (2003) Plasma platelet activating factor-acetylhydrolase (PAF-AH). Prog Lipid Res 42:93-114
20. Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, Schimpf B, Hooper S, Trong HL, Cousens LS, Zimmerman GA, Yamada Y, McIntyre TM, Prescott SM, Gray PW (1995) Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549-553
21. Grypioti AD, Theocharis SE, Papadimas GΚ, Demopoulos CΑ, Papadopoulou-Daifoti Z, Basayiannis ΑC, Μykoniatis ΜG (2005) Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration. Arch Toxicol 79:466-474
22. Tygstrup N, Jensen SA, Krog B, Dalhoff K (1997) Expression of liver functions following sub-lethal and non-lethal doses of allyl alcohol and acetaminophen in the rat. J Hepatol 27:156-162
23. Munro HN, Fleck A (1966) Recent developments in the measurement of nucleic acids in biological materials. Analyst 91:78-88
24. Kyprianidis KG, Mykoniatis MG, Papadimitriou DG, Valsamidou AJ (1996) Effect of subtotal pancreatectomy on the rate of liver regeneration: the role of hepatic stimulator substance. J Surg Res 62:267-272
25. Richards GM (1974) Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem 57:369-376
26. Kahn D, Svanas GW, Eagon PK, Makowka L, Podesta L, Chapchap P, Starzl TE, Van Thiel DH (1988) Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in rats. J Lab Clin Med 112:232-239
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
28. O'Grady JG (1997) Paracetamol-induced acute liver failure: prevention and management. J Hepatol 1:41-46
29. Bailey B, Amre DK, Gaudreault P (2003) Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 31:299-305
30. Lee WM (2004) Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 40:6-9
31. Bartlett D (2004) Acetaminophen toxicity. J Emerg Nurs 30:281-283
32. James LP, Mayeux PR, Hinson JA (2003) Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 31:1499-1506
33. Bromer MQ, Black M (2003) Acetaminophen hepatotoxicity. Clin Liver Dis 7:351-367
34. Dargan PI, Jones AL (2002) Acetaminophen poisoning: an update for the intensivist. Crit Care 6:108-110
35. Jaeschke H (1990) Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther 255:935-941
36. Knight TR, Kurtz A, Bajt ML, Hinson JA, Jaeschke H (2001) Vascular and hepatocellular peroxynitrite formation during acetaminophen-induced liver injury: role of mitochondrial oxidant stress. Toxicol Sci 62:212-220
37. Jaeschke H (2003) Oxidant stress precedes liver injury after acetaminophen in cultured mouse hepatocytes. Toxicol Sci 72:10 (abstract)
38. Knight TR, Ho YS, Farhood A, Jaeschke H (2002) Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther 303:468-475
39. Zhou W, Chao W, Levine BA, Olson MS (1992) Role of platelet-activating factor in hepatic responses after bile duct ligation in rats. Am J Physiol 263:G587-G592
40. Zhou W, McCollum MO, Levine BA, Olson MS (1992) Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology 16:1236-1240
41. Bedirli A, Gokahmetoglu S, Sakrak O, Soyuer I, Ince O, Sozuer E (2004) Beneficial effects of recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis. Eur Surg Res 36:136-141
42. Hofbauer B, Saluja AK, Bhatia M, Frossard JL, Lee HS, Bhagat L, Steer ML (1998) Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology 115:1238-1247
43. Lee ES, Jiang J, Sund GC, Simonson WT, Graham J, Dietsch G, Schimpf B, Bieg S, Peterman G, Lernmark A (1999) Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes 48:43-49
44. Marathe GK, Harisson KA, Roberts II LJ, Morrow JD, Murphy RC, Tjoelker LW, Prescott SM, Zimmerman GA, McIntyre TM (2001) Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. J Lipid Res 42:587-596
45. Anderson BO, Bensard DD, Harken AH (1991) The role of platelet-activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet 172:415-424
46. Shimizu T, Honda Z, Nakamura M, Bito H, Izumi T (1992) Platelet-activating factor receptor and signal transduction. Biochem Pharmacol 44:1001-1008
47. Mizuno S, Izumi T, Isaji S (2001) Role of PAF in acute liver injury after extended hepatectomy: overexpression of PAF receptor mRNA in Kupffer cells. Dig Dis Sci 46:1299-1304
48. Yang Y, Harvey SAK, Gandhi CR (2003) Kupffer cells are a major source of increased platelet-activating factor in the CCl4-induced cirrhotic rat liver. J Hepatol 39:200-207
49. Chao W, Liu H, De Buysere M, Hanahan DJ, Olson MS (1989) Identification of receptors for platelet activating factor in rat Kupffer cells. J Biol Chem 64:13591-13598
50. 2+ concentrations in cultured rat Kupffer cells. FEB Lett 251:22-26
51. Taub R (2004) Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5:836-847
52. Prescott LF (2003) New perspectives on paracetamol. Drugs 63:51-56
53. Ray SD, Jena N (2000) A hepatotoxic dose of acetaminophen modulates expression of BCL-2, BCL-X(L), and BCL-X(S) during apoptotic and necrotic death of mouse liver cells in vivo. Arch Toxicol 73:594-606
54. Takada Y, Shimahara Y, Yamaguchi T, Nishizawa F, Mori K, Yamaoka Y, Ozawa K (1992) Protective effect of platelet-activating factor antagonist on hepatic energy metabolism following transient hepatic inflow occlusion in rabbits. Circ Shock 38:130-137
55. Nishihira T, Tanaka J, Nishikawa K, Jikko A, Taki Y, Morimoto T, Koizumi K, Kamiyama Y, Ozawa K, Tobe T (1986) Biological significance of enhanced mitochondrial membrane potential in regenerating liver. Hepatology 6:220-224
56. Atkinson DE (1968) The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7:4030-4034